I’ve started this week by diving into stocks in the Materials sector. The market’s rally over the last week or so has been good for a number of sectors, including Materials, as economic indicators show that the U.S. remains healthy. Volatility in the oil market can wreak havoc at times with some of the stocks […]
Read MoreBuy Target – $12.00 or better Sell Target – TradersPro Sell Signal Telaria, Inc. provides a software platform for publishers to manage and monetize video advertising in the United States. The company offers publishers with real-time analytics, data, and decisioning tools to control their video advertising business, as well as a monetization solution to optimize […]
Read MoreBy the end of last week, all of the major indices had pushed to or near a fresh set of all-time highs. The broad rally that began when the U.S. and China officially signed Phase One of what everybody hopes is a long-term trade deal gave the markets plenty of incentive to start looking into […]
Read MoreBuy Target – $9.00 or better Sell Target – TradersPro Sell Signal Equinox Gold Corp. engages in the acquisition, exploration, and development of mineral deposits. The company’s principal properties include the Aurizona gold mine covering a total land package of approximately 2,000 square kilometers located in Maranhão State, Brazil; and the Mesquite gold mine covering […]
Read MorePlus, Tesla priced its secondary offering and issued a recall of its Model X SUVs in North America, and AstraZeneca posted plunging profits.
Read MoreIt’s interesting to see how market dynamics affect different industries and sectors of the economy at different points in time. Historical trends and norms prompt us to categorize certain areas of the market as “defensive” or “cyclical,” “aggressive” or “conservative” simply because of the way the price activity those areas, or even individual stocks have […]
Read MoreTesla may be getting all the headlines, but this legacy automaker is the one to watch now.
Read MoreThis retailer may have massive hit this week, but there could be double-digit upside on the horizon. Here’s why.
Read MoreThis drugmaker has a promising treatment for the virus and one expert says the stock’s technical picture makes it a buy now.
Read MoreBuy Target – $17.50 or better Sell Target – TradersPro Sell Signal Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline include XEN496, A Kv7 potassium channel modulator that is Phase II clinical trials for the treatment of KCNQ2 epilepsy; XEN1101, […]
Read MorePlus, MGM Resorts’ chairman and CEO steps down as the casino operator withdraws its financial forecast for 2020, and Pepsi and Incyte report earnings.
Read MoreWhile investors have been anxious to find reasons to shrug off fears about the economic impact of coronavirus, there are certainly some individual cases where those risks can’t really be ignored. One in the Leisure & Recreation Services industry, which includes cruise line companies. News reports of cruise ships filled with passengers that have been […]
Read MoreThese 4 energy stocks are primed for massive upside ahead. Here’s why.
Read MoreThis group of stocks has been facing mighty headwinds recently, but the technical picture says the group is gearing up to surge higher.
Read MoreTrade Setup Buy Target $59.48 Sell Target $65.02 CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious diseases. The company develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), a revolutionary gene editing technology that allows for precise directed changes to genomic DNA. It […]
Read More